Biocept Inc (NASDAQ:BIOC)
| 0.2949 Delayed Data As of Mar 24 |  -0.0051 / -1.70%Today’s Change | 0.24 Today|||52-Week Range 2.43 | -44.36% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 822.2K | 761.6K | 859.5K | 1.0M | |
| Cost of Goods Sold | 2.5M | 2.3M | 2.2M | 2.4M | ||
| Depreciation And Amortization | 177.4K | 223.2K | 220.5K | 184.3K | ||
| Operating Expenses | Gross Income | -1.9M | -1.7M | -1.6M | -1.6M | |
| General Expenses | 4.2M | 4.3M | 4.4M | 4.3M | ||
| Research And Development | 1.0M | 1.1M | 1.3M | 1.2M | ||
| Total Operating Expenses | 6.9M | 6.8M | 6.8M | 6.9M | ||
| Non-Operating Expenses | Operating Income | -6.0M | -6.0M | -5.9M | -5.9M | |
| Interest Expense On Debt | 84.2K | 63.8K | 80.3K | 62.0K | ||
| Other Expenses | -30.0K | 24.0K | 6.0K | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -6.2M | -6.0M | -6.0M | -5.9M | |
| Income Taxes | 0.00 | 0.00 | -1.1K | 0.00 | ||
| Preferred Dividend | 0.00 | -636.4K | 0.00 | -99.7K | ||
| Net Income | -6.2M | -6.0M | -6.0M | -5.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.3M | 2.8M | 4.2M | 9.8M | |
| Shares To Calculate EPS Diluted | 2.3M | 2.8M | 4.2M | 9.8M | ||
| Earnings Per Share | EPS | -$2.70 | -$2.42 | -$1.43 | -$0.61 | |
| EPS Diluted | -$2.70 | -$2.42 | -$1.43 | -$0.61 | ||
